SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Renmanco who wrote (48019)12/10/2018 3:48:05 PM
From: Planeteer6 Recommendations

Recommended By
bluelakes
CelebrityEquity
drtom1234
JJINV
patlawche11

and 1 more member

   of 63283
 
The more I think about this, it might be one of the best possible outcomes to explain the reticence at the CC.... this is an actionable tangible issue which can be addressed (and I would hope is already addressed) with appropriate administrative execution.... it is vastly preferable to other situations.

Hopefully this is the type of release that dots some i's and crosses some t's in advance of approval. Nowhere does it indicate there is any fundamental issue with the drug, but there was a lack of perfection /following of protocol in production.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News